Roche launched new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
On Sept. 18, 2020, Roche announced the launch of its Elecsys Anti-SARS-CoV-2 S antibody test for markets accepting…
-
-
Rigel announced NIH/NHLBI-sponsored trial of fostamatinib in hospitalized COVID-19 patients in collaboration with Inova
On Sept. 17, 2020, Rigel Pharma announced the start of a multicenter, Phase 2 trial to evaluate the…
-
Quest Diagnostics announced COVID-19 Diagnostic test options for active COVID-19 infection through QuestDirect
On Sept. 17, 2020, Quest Diagnostics announced that individuals can purchase a test to diagnose COVID-19 online, without…
-
3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos Medical and NLC Pharma
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
-
AIM ImmunoTech announced start of recruitment in clinical trial incorporating Ampligen in treatment of cancer patients with COVID-19
On Sept. 16, 2020, AIM ImmunoTech announced that recruitment had begun in Roswell Park Comprehensive Cancer Center’s Phase…
-
AXIM Biotechnologies filed Emergency Use Authorization with COVID-19 rapid diagnostic test for neutralizing antibodies
On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…
-
Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of India
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…
-
Arizona COVID-19 Genomics Union tracked strains of SARS-CoV-2
On Sept. 15, 2020, initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggested that following Arizona’s…
-
NIH awarded contracts worth $22.8 million to develop innovative digital health technologies for COVID-19
On Sept. 15, 2020, the National Institutes of Health (NIH) awarded seven contracts worth a total of $22.8…
-
FDA contracted with global partners to analyze coronavirus samples
On Sept. 15, 2020, the U.S. Food and Drug Administration (FDA) awarded a $5.4 million research contract to…
-
Thermo Fisher Scientific further expanded laboratory plastics production to support COVID-19 testing, therapies and vaccines
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
-
Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
On Sept. 15, 2020, Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare…
-
OPKO Health initiated clinical trial of RAYALDEE in COVID-19 patients
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEﾮ as a…
-
BioNTech received €375M in funding from German Federal Ministry to support COVID-19 vaccine program BNT162
On Sept. 15, 2020, BioNTech announced that it will receive a grant of up to 375 million Euro…
-
Factors inherent to obesity could increase vulnerability to COVID-19
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
-
Valneva announced COVID-19 vaccine partnership with UK Government
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
-
Genomic leaders collaborated to create Australia’s first national COVID-19 tracking system
On Sept. 14, 2020, Illumina announced that the Australian public health laboratories will aim to sequence the virus…
-
Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
-
Meridian launched novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva
On Sept. 14, 2020, Meridian Bioscience announced the launch of a novel highly sensitive SARS-CoV-2 antibody pair to…
-
Biotechnology | Clinical Research | COVID-19 | FDA | Vaccine
BioNTech and Pfizer proposed expansion of pivotal COVID-19 vaccine trial
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
-
Transmission of COVID-19 outbreaks associated with child care facilities in Utah
On Sept. 11, 2020, the U.S. Centers for Disease Control and Prevention (CDC) reported that twelve children acquired…
-
Todos Medical announced commercial launch of COVID-19 qPCR test kits in the U.S.
On Sept. 11, 2020, Todos Medical announced that the U.S. Food and Drug Administration (FDA) has added the…
-
Pfizer and BioNTech announced data from preclinical studies of mRNA-based vaccine candidate against COVID-19
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
-
U.S. COVID-19 cases may be substantially underestimated
On Sept. 9, 2020, UC Berkeley School of Public Health researchers reported that probability analysis showed the U.S….
-
AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary paused
On Sept. 9, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
-
US Government stopped COVID-19 entry strategy for international air passengers
On Sept. 9, 2020, the U.S. government (USG) announced that it will remove requirements for directing all flights…
-
Elevated levels of a blood clotting factor linked to worse outcomes in severe COVID-19
On Sept. 9, 2020, Harvard Medical School investigators at Massachusetts General Hospital reported that patients hospitalized with severe…
-
Head-to-head study demonstrated equivalency and accuracy of COVID-19 rapid point-of-care tests, despite test sensitivity claims
On Sept. 9, 2020, BD (Becton, Dickinson) announced the results of a new research study that demonstrated performance…
-
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Medicine | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency and the Chan Zuckerberg Initiative partnered to create COVID-19 database
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
-
Vaxart’s oral COVID-19 vaccine candidate induced potent systemic and mucosal immune responses in preclinical studies
On Sept. 8, 2020, Vaxart announced pre-publication of a manuscript titled “Preclinical studies of a recombinant adenoviral mucosal…
